4//SEC Filing
McKenna Mark C. 4
Accession 0001104659-24-128588
CIK 0001974640other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 6:00 AM ET
Size
7.2 KB
Accession
0001104659-24-128588
Insider Transaction Report
Form 4
McKenna Mark C.
Director
Transactions
- Purchase
Common Stock
2024-12-12$49.85/sh+12,500$623,125→ 20,000 total - Purchase
Common Stock
2024-12-12$49.02/sh+7,500$367,650→ 7,500 total
Footnotes (2)
- [F1]The price reported above is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $48.50 to $49.48, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range.
- [F2]The price reported above is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $49.6275 to $50.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range.
Documents
Issuer
Apogee Therapeutics, Inc.
CIK 0001974640
Entity typeother
Related Parties
1- filerCIK 0001749623
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 6:00 AM ET
- Size
- 7.2 KB